{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:55:22Z","timestamp":1761490522806,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03DA036208"],"award-info":[{"award-number":["R03DA036208"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.vascn.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T14:44:54Z","timestamp":1521211494000},"page":"52-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Development of serotonin transporter reuptake inhibition assays using JAR cells"],"prefix":"10.1016","volume":"92","author":[{"given":"Ann M.","family":"Decker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2018.03.003_bb0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.ne.16.030193.000445","article-title":"Neurotransmitter transporters - recent progress","volume":"16","author":"Amara","year":"1993","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.vascn.2018.03.003_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0376-8716(98)00068-4","article-title":"Neurotransmitter transporters as molecular targets for addictive drugs","volume":"51","author":"Amara","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.vascn.2018.03.003_bb0015","first-page":"33","article-title":"Synaptosomes. A model system to study release of multiple classes of neurotransmitters","volume":"72","author":"Breukel","year":"1997","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.vascn.2018.03.003_bb0020","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.vascn.2018.03.003_bb0025","doi-asserted-by":"crossref","first-page":"15750","DOI":"10.1016\/S0021-9258(18)98473-5","article-title":"Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR)","volume":"266","author":"Cool","year":"1991","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.vascn.2018.03.003_bb0030","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3565(24)38214-X","article-title":"Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type","volume":"289","author":"Eshleman","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2018.03.003_bb0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.vascn.2018.03.003_bb0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bcp.2007.08.003","article-title":"Monoamine transporters and psychostimulant addiction","volume":"75","author":"Howell","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.vascn.2018.03.003_bb0045","first-page":"304","article-title":"Uptake and storage of m-iodobenzylguanidine are frequent neuronal functions of human neuroblastoma cell lines","volume":"53","author":"Iavarone","year":"1993","journal-title":"Cancer Research"},{"key":"10.1016\/j.vascn.2018.03.003_bb0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.mp.4000728","article-title":"Neurotransmitter transporters: Fruitful targets for CNS drug discovery","volume":"5","author":"Iversen","year":"2000","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.vascn.2018.03.003_bb0055","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1016\/S0021-9258(17)36640-1","article-title":"Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells","volume":"269","author":"Jayanthi","year":"1994","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.vascn.2018.03.003_bb0060","doi-asserted-by":"crossref","first-page":"54380","DOI":"10.1074\/jbc.M409282200","article-title":"Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter","volume":"279","author":"Jiang","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.vascn.2018.03.003_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneumeth.2007.12.004","article-title":"Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity","volume":"169","author":"Jorgensen","year":"2008","journal-title":"Journal of Neuroscience Methods"},{"key":"10.1016\/j.vascn.2018.03.003_bb0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lfs.2004.08.007","article-title":"The effect of a series of organic cations upon the plasmalemmal serotonin transporter, SERT","volume":"76","author":"Keating","year":"2004","journal-title":"Life Sciences"},{"key":"10.1016\/j.vascn.2018.03.003_bb0075","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0022-3565(24)35386-8","article-title":"Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta","volume":"292","author":"Kekuda","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.vascn.2018.03.003_bb0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1053\/plac.2002.0917","article-title":"Uptake of 1-methyl-4-phenylpyridinium (MPP+) by the JAR human placental choriocarcinoma cell line: Comparison with 5-hydroxytryptamine","volume":"24","author":"Martel","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.vascn.2018.03.003_bb0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0031-6997(24)01414-5","article-title":"Neurotransmitter transporters in the central nervous system","volume":"51","author":"Masson","year":"1999","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.vascn.2018.03.003_bb0090","series-title":"Neurotransmitter transporters","first-page":"41","article-title":"Interrogating the activity of ligands at monoamine transporters in rat brain synaptosomes","author":"Partilla","year":"2016"},{"key":"10.1016\/j.vascn.2018.03.003_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0143-4004(96)90039-9","article-title":"Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells","volume":"17","author":"Prasad","year":"1996","journal-title":"Placenta"},{"key":"10.1016\/j.vascn.2018.03.003_bb0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF03033178","article-title":"Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists","volume":"5","author":"Presgraves","year":"2004","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.vascn.2018.03.003_bb0105","doi-asserted-by":"crossref","first-page":"17189","DOI":"10.1074\/jbc.270.29.17189","article-title":"Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells","volume":"270","author":"Ramamoorthy","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.vascn.2018.03.003_bb0110","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1073\/pnas.90.6.2542","article-title":"Antidepressant- and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization","volume":"90","author":"Ramamoorthy","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.vascn.2018.03.003_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","article-title":"Monoamine transporters and psychostimulant drugs","volume":"479","author":"Rothman","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2018.03.003_bb0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/syn.890140106","article-title":"Identification of a Gbr12935 homolog, Lr1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters","volume":"14","author":"Rothman","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.vascn.2018.03.003_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0005-2728(93)90109-S","article-title":"From synapse to vesicle - the reuptake and storage of biogenic-amine neurotransmitters","volume":"1144","author":"Rudnick","year":"1993","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.vascn.2018.03.003_bb0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1471-4159.2000.0750511.x","article-title":"Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine","volume":"75","author":"Seitz","year":"2000","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.vascn.2018.03.003_bb0135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: A review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Progress in Neurobiology"},{"key":"10.1016\/j.vascn.2018.03.003_bb0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: A vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2018.03.003_bb0145","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1124\/mol.108.048546","article-title":"Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells","volume":"74","author":"Watabe","year":"2008","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.vascn.2018.03.003_bb0150","doi-asserted-by":"crossref","first-page":"E421","DOI":"10.1208\/aapsj070242","article-title":"Serotonin transporters: Implications for antidepressant drug development","volume":"7","author":"White","year":"2005","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.vascn.2018.03.003_bb0155","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.bcp.2007.11.019","article-title":"Lobeline effects on tonic and methamphetamine-induced dopamine release","volume":"75","author":"Wilhelm","year":"2008","journal-title":"Biochemical Pharmacology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871917305336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871917305336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:01:37Z","timestamp":1761004897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871917305336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":31,"alternative-id":["S1056871917305336"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2018.03.003","relation":{},"ISSN":["1056-8719"],"issn-type":[{"type":"print","value":"1056-8719"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of serotonin transporter reuptake inhibition assays using JAR cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}